Literature DB >> 28676981

Comment on "Patient Reporting in the EU: Analysis of EudraVigilance Data".

Farid Kheloufi1,2, Anne Default1,2, Frank Rouby1,2, Olivier Blin1,2, Joelle Micallef3,4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28676981     DOI： 10.1007/s40264-017-0568-4

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  11 in total

Review 1.  ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Authors:  Linda Härmark; Florence van Hunsel; Birgitta Grundmark
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

Review 2.  21st century pharmacovigilance: efforts, roles, and responsibilities.

Authors:  Peter J Pitts; Hervé Le Louet; Yola Moride; Rena M Conti
Journal:  Lancet Oncol       Date:  2016-11       Impact factor: 41.316

3.  Causality assessment in pharmacovigilance: The French method and its successive updates.

Authors:  Ghada Miremont-Salamé; Hélène Théophile; Françoise Haramburu; Bernard Bégaud
Journal:  Therapie       Date:  2016-02-06       Impact factor: 2.070

Review 4.  The value of patient reporting to the pharmacovigilance system: a systematic review.

Authors:  Pedro Inácio; Afonso Cavaco; Marja Airaksinen
Journal:  Br J Clin Pharmacol       Date:  2016-10-12       Impact factor: 4.335

5.  Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?

Authors:  F Kheloufi; A Default; F Rouby; D Laugier-Castellan; M Boyer; B Rodrigues; J Ponte-Astoul; M J Jean-Pastor; O Blin; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2017-04-08       Impact factor: 2.953

6.  First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Authors:  Geneviève Durrieu; Aurore Palmaro; Laure Pourcel; Céline Caillet; Angeline Faucher; Alexis Jacquet; Shéhérazade Ouaret; Marie Christine Perault-Pochat; Carmen Kreft-Jais; Anne Castot; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

7.  [Adverse drug reactions: a pilot study on patient reporting through patient associations].

Authors:  Daphney Nasrallah-Irles; Anne Castot; Laure Thomas; Samy Babai; Bernard Delorme; Hervé Le-Louët
Journal:  Therapie       Date:  2009-01-21       Impact factor: 2.070

8.  Adverse drug reaction reports of patients and healthcare professionals-differences in reported information.

Authors:  Leàn Rolfes; Florence van Hunsel; Sarah Wilkes; Kees van Grootheest; Eugène van Puijenbroek
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-07-31       Impact factor: 2.890

9.  The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.

Authors:  Leàn Rolfes; Florence van Hunsel; Laura van der Linden; Katja Taxis; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

10.  vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.

Authors:  Tomas Bergvall; G Niklas Norén; Marie Lindquist
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606
View more
  1 in total

1.  Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database.

Authors:  Leàn Rolfes; Florence van Hunsel; Ola Caster; Henric Taavola; Katja Taxis; Eugène van Puijenbroek
Journal:  Br J Clin Pharmacol       Date:  2018-04-19       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.